HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antihypertensive effect of Carica papaya via a reduction in ACE activity and improved baroreflex.

Abstract
The aims of this study were to evaluate the antihypertensive effects of the standardised methanolic extract of Carica papaya, its angiotensin converting enzyme inhibitory effects in vivo, its effect on the baroreflex and serum angiotensin converting enzyme activity, and its chemical composition. The chemical composition of the methanolic extract of C. papaya was evaluated by liquid chromatography-mass/mass and mass/mass spectrometry. The angiotensin converting enzyme inhibitory effect was evaluated in vivo by Ang I administration. The antihypertensive assay was performed in spontaneously hypertensive rats and Wistar rats that were treated with enalapril (10 mg/kg), the methanolic extract of C. papaya (100 mg/kg; twice a day), or vehicle for 30 days. The baroreflex was evaluated through the use of sodium nitroprusside and phenylephrine. Angiotensin converting enzyme activity was measured by ELISA, and cardiac hypertrophy was evaluated by morphometric analysis. The methanolic extract of C. papaya was standardised in ferulic acid (203.41 ± 0.02 µg/g), caffeic acid (172.60 ± 0.02 µg/g), gallic acid (145.70 ± 0.02 µg/g), and quercetin (47.11 ± 0.03 µg/g). The flavonoids quercetin, rutin, nicotiflorin, clitorin, and manghaslin were identified in a fraction of the extract. The methanolic extract of C. papaya elicited angiotensin converting enzyme inhibitory activity. The antihypertensive effects elicited by the methanolic extract of C. papaya were similar to those of enalapril, and the baroreflex sensitivity was normalised in treated spontaneously hypertensive rats. Plasma angiotensin converting enzyme activity and cardiac hypertrophy were also reduced to levels comparable to the enalapril-treated group. These results may be associated with the chemical composition of the methanolic extract of C. papaya, and are the first step into the development of a new phytotherapic product which could be used in the treatment of hypertension.
AuthorsGirlandia Alexandre Brasil, Silas Nascimento Ronchi, Andrews Marques do Nascimento, Ewelyne Miranda de Lima, Wanderson Romão, Helber Barcellos da Costa, Rodrigo Scherer, José Aires Ventura, Dominik Lenz, Nazaré Souza Bissoli, Denise Coutinho Endringer, Tadeu Uggere de Andrade
JournalPlanta medica (Planta Med) Vol. 80 Issue 17 Pg. 1580-7 (Nov 2014) ISSN: 1439-0221 [Electronic] Germany
PMID25295669 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightGeorg Thieme Verlag KG Stuttgart · New York.
Chemical References
  • Antihypertensive Agents
  • Plant Extracts
Topics
  • Animals
  • Antihypertensive Agents (chemistry, isolation & purification, pharmacology)
  • Baroreflex (drug effects)
  • Carica (chemistry)
  • Chromatography, Liquid
  • Mass Spectrometry
  • Plant Extracts (chemistry, isolation & purification, pharmacology)
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: